340 related articles for article (PubMed ID: 22394688)
1. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
2. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
Batista PA; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
[TBL] [Abstract][Full Text] [Related]
4. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
5. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats.
Fogaça MV; Gomes FV; Moreira FA; Guimarães FS; Aguiar DC
Psychopharmacology (Berl); 2013 Apr; 226(3):579-87. PubMed ID: 23183551
[TBL] [Abstract][Full Text] [Related]
6. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats.
Resstel LB; Lisboa SF; Aguiar DC; Corrêa FM; Guimarães FS
Psychopharmacology (Berl); 2008 Jun; 198(3):405-11. PubMed ID: 18446325
[TBL] [Abstract][Full Text] [Related]
7. CB
Dos Anjos-Garcia T; Ullah F; Falconi-Sobrinho LL; Coimbra NC
Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
[TBL] [Abstract][Full Text] [Related]
8. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
Batista LA; Bastos JR; Moreira FA
J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.
Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1517-21. PubMed ID: 19735690
[TBL] [Abstract][Full Text] [Related]
10. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray.
Lisboa SF; Camargo LH; Magesto AC; Resstel LB; Guimarães FS
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1193-206. PubMed ID: 24438603
[TBL] [Abstract][Full Text] [Related]
12. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of anandamide on rat placenta nitric oxide synthesis.
Cella M; Leguizamón GF; Sordelli MS; Cervini M; Guadagnoli T; Ribeiro ML; Franchi AM; Farina MG
Placenta; 2008 Aug; 29(8):699-707. PubMed ID: 18561998
[TBL] [Abstract][Full Text] [Related]
15. NOC-9, a selective nitric oxide donor, induces flight reactions in the dorsolateral periaqueductal gray of rats by activating soluble guanylate cyclase.
Braga AA; Aguiar DC; Guimarães FS
Neurosci Lett; 2009 Aug; 459(2):79-83. PubMed ID: 19427360
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
17. Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation.
Gervasi MG; Osycka-Salut C; Caballero J; Vazquez-Levin M; Pereyra E; Billi S; Franchi A; Perez-Martinez S
PLoS One; 2011 Feb; 6(2):e16993. PubMed ID: 21347292
[TBL] [Abstract][Full Text] [Related]
18. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.
Back FP; Carobrez AP
Neuropharmacology; 2018 Jun; 135():399-411. PubMed ID: 29596901
[TBL] [Abstract][Full Text] [Related]
19. Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.
Munguba H; Cabral A; Leão AH; Barbosa FF; Izídio GS; Ribeiro AM; Silva RH
Neurobiol Learn Mem; 2011 May; 95(4):527-33. PubMed ID: 21440651
[TBL] [Abstract][Full Text] [Related]
20. Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey.
Gobira PH; Almeida-Santos AF; Guimaraes FS; Moreira FA; Aguiar DC
Eur Neuropsychopharmacol; 2016 Jan; 26(1):15-22. PubMed ID: 26628106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]